Advanced Search:
Equity Index Forex Crypto Commodity

MRNA - Moderna

$105.14  -1.87 (-1.75%)

Updated: 03:13 May 5, 2024 EST

Next Hour's AI Forecast

96.14%

Avg. Accuracy (AI)

$127.22

Next Session's AI Forecast

92.01%

Avg. Accuracy (AI)

$102.2

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

$116.96

Moderna's Position Within the Biotechnology Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

MODERNA - HISTORICAL DATA 6M

  • Last price

    $ 105.14

  • Daily change

    $ -1.87

  • Previous Close

    $ 107.01

  • Last Updated

    03:13 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-1.23 0.44 0.63 0.48 -0.02

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.23 2.15 2.55 2.5 2.38

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 74.35% 81.31% 88.76%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
121.7 6.58% 114.19 5.22% 108.53 13.7% 95.45

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.72 13.79 3.18 41.86

Moderna Technical Analysis News

Moderna

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sectors: Healthcare
Industry: Biotechnology
F. Time Employees: 5600
Description

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Moderna, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 9; Compensation: 9.

MODERNA'S HOLDERS RANK

List of holders with stock participation in Moderna.

Holder Rank Holder Shares Date Reported % Out Value